Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alopecia, Alopecia totalis, Cardiac disorder
Clinical narrative: Heartache; Pfizer COVID 19 Vaccines (2) triggered Alopecia Totalis; lost her hair because of the covid vaccine/has lost all of her hair, has no eye lashes; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program (002591; 005570). The reporter is the patient.  A 71 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 21Feb2021 (Batch/Lot number: unknown) at the age of 71 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Alopecia Areata" (unspecified if ongoing), notes: I had been controlling Alopecia Areata by routine Steroid injections. There were no concomitant medications. Vaccination history included: Bnt162b2 (Dose: 1, LOT-unknown, left arm), administration date: 21Jan2021, when the patient was 71 years old, for COVID-19 Immunisation. The following information was reported: ALOPECIA (non-serious) with onset Feb2021, outcome "not recovered", described as "lost her hair because of the covid vaccine/has lost all of her hair, has no eye lashes"; CARDIAC DISORDER (non-serious), outcome "unknown", described as "Heartache"; ALOPECIA TOTALIS (non-serious) with onset Feb2021, outcome "unknown", described as "Pfizer COVID 19 Vaccines (2) triggered Alopecia Totalis". Therapeutic measures were taken as a result of alopecia totalis. Additional information: Female patient received tofacitinib citrate (XELJANZ), via oral from an unspecified date (Batch/Lot number was not reported) to an unspecified date, at 5 mg, twice a day (5 mg PO Quantity 60 (30 days)) for alopecia totalis and help to grow her lashes and her hair back (Alopecia). On Prescription Information and Enrollment Form Reviewed used for L63.0 Alopecia Totalis. Upon follow up (18Nov2021, 18Nov2021 and 22Nov2021): During inbound call with patient, she said that she lost her hair because of the covid vaccine, Patient was prescribed Xeljanz 5 mg. The caller stated the medication had not been prescribed yet. Agent stated the caller had to speak with someone else, she wanted Xeljanz to helped grow her lashes and her hair back, doctor recommended the Xeljanz for hair growth, this was an off label use. Doctor had not yet prescribed medication, stated they would liked to. She wanted Pfizer to gave her some Xeljanz, stated Pfizer owes her for her experience with the Pfizer Covid vaccine and losing her hair. Caller stated that since she had the second dose of the Pfizer Covid vaccine last Feb2021, she had lost all her hair, she had no eyelashes, stated her doctor submitted documentation to support that she would be a perfect candidate to try Xeljanz and had been assigned an appeal number, stated she read the information they gave her, read that there was a counter measures injury compensation program, stated she was requesting help here, wanted to try the Xeljanz. Caller stated she was wearing wigs to cover the hair loss. Stated it started within a few days of the second dose and within two weeks she was pretty much bald, states she has no eyelashes and was losing hair everywhere. Stated it had not gotten better and it could not get any worse. Patient took vaccine on 12Jan2021 and 21Feb2021 left arm.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.  Follow-up (18Nov2021): New information received from a contactable consumer (patient) reported for herself that: patient details, events details-medication prescribed for off label use, case narrative and additional information.   No follow-up attempts are possible. No further information is expected.  Follow-up (18Nov2021): New information received from a contactable consumer (patient) reported for herself that: patient age at vaccination, unit weight and height, events description and outcome-has lost all of her hair, has no eye lashes , suspect product details, case narrative and additional information.  No follow-up attempts are possible. No further information is expected.  Follow-up (22Nov2021): New information received in response to the mail trail sent regarding the confirmation of query confirm the ID for Pfizer Support.  Follow-up attempts are completed. No further information is expected.  Follow-up (10Dec2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.  Follow-up (03Mar2022): New information received from a contactable Consumer (patient)  included new event added, New Suspect drug "Ritlecitinib", seriousness and additional information and Customer Verbatim: The Pfizer COVID 19 Vaccines (2) triggered Alopecia Totalis. I had been controlling Alopecia Areata by routine Steroid injections. My Dermatologist believes Xeljanz will help me. I have submitted paperwork to company and been denied. I have read about Allegro. When will Allegro become available? I would sincerely appreciate Pfizer coming forward to aid me since their vaccines caused me this Heartache.   The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.